Australia: Telix expands urology treatment pipeline with acquisition of Lightpoint Medical

Australian nuclear medicine company, Telix Pharmaceuticals, has entered into an agreement to acquire Lightpoint Medical and its Sensei radio-guided surgery business. Lightpoint Medical is a UK -based medical device company specialising in the intra-operative detection of targeted radiopharmaceuticals. The purchase price is split US$20m upfront, paid in equity at completion, and a further US$15m earn-out…